| LZ ALPHA | FRI · SEP 11, 2026 · 06:00 EST · ISSUE #253 |
The overnight SEC tape is heavy with balance-sheet moves: big-cap debt issuance, a takeout, and one acquisition with real integration risk buried in the 8-K text. Congressional disclosures are pulled from the most recent available filings rather than a full overnight batch, while Form 4s delivered a clear CEO-buy signal at Uber and Celsius.
| Type | Ticker | Signal | Flagged | Then | Now | Return |
|---|---|---|---|---|---|---|
| 8-K | QBTS | D-Wave Quantum Inc. | 2026-09-10 | $17.67 | $16.66 | ▼ 5.7% |
| 8-K | WAFD | WaFd, Inc. | 2026-09-09 | $34.28 | $34.10 | ▼ 0.5% |
| 8-K | ARDT | Ardent Health, Inc. | 2026-09-05 | $10.76 | $10.90 | ▲ 1.3% |
This six-trade filing is all full sales by the spouse account: AMZN at $100,001-$250,000, MCD and NVDA at $15,001-$50,000 each, plus smaller full exits in JD, ALNY and NFLX. The trades were dated August 11 and filed September 9.
The signal is broad de-risking rather than a single-company call, with large-cap internet, AI hardware, consumer, China ADR and biotech exposure all reduced at once. The Amazon sale is the anchor given its size and Booker's national profile.
| AMZN | Sell | STOCK | $100,001 - $250,000 |
| MCD | Sell | STOCK | $15,001 - $50,000 |
| NVDA | Sell | STOCK | $15,001 - $50,000 |
| JD | Sell | STOCK | $1,001 - $15,000 |
| ALNY | Sell | STOCK | $1,001 - $15,000 |
| NFLX | Sell | STOCK | $1,001 - $15,000 |
The filing reports one PG purchase in the $1,001-$15,000 range, explicitly described as an automatic reinvestment of dividends earned. The transaction occurred August 17 and was filed September 8.
This is low-conviction as a discretionary signal because the comment identifies it as automatic dividend reinvestment. It still matters for completeness, but it ranks behind active multi-name filings and higher-dollar reallocations.
The filing contains six trades, each in the $1,001-$15,000 range: full sales of VRTX, MSFT and AMGN, and purchases of FITB, AVGO and AEP. All transactions were dated August 26 and filed 10 days later.
The pattern looks like a modest sector rotation out of mega-cap software and healthcare into semis, regional banking and utilities. The individual dollar bands are small, but the mix touches policy-sensitive sectors including banks, power demand and drug pricing.
| VRTX | Sell | STOCK | $1,001 - $15,000 |
| MSFT | Sell | STOCK | $1,001 - $15,000 |
| FITB | Buy | STOCK | $1,001 - $15,000 |
| AVGO | Buy | STOCK | $1,001 - $15,000 |
| AMGN | Sell | STOCK | $1,001 - $15,000 |
| AEP | Buy | STOCK | $1,001 - $15,000 |
The filing discloses the largest 6 of 66 trades, including a $100,001-$250,000 full sale of BABA, purchases of MSB, ALKS and MSFT, a sale of CRNX, and an NSA exchange tied to Public Storage's acquisition. The MSFT purchase was marked late at 49 days to file.
This is the largest congressional filing in the batch by potential disclosed value, with up to $1.47 million across a broad single-member portfolio turnover. The China-tech exit, biotech churn, REIT merger exchange, and late Big Tech purchase make the overall pattern more important than any one line item.
| BABA | Sell | STOCK | $100,001 - $250,000 |
| MSB | Buy | STOCK | $15,001 - $50,000 |
| CRNX | Sell | STOCK | $15,001 - $50,000 |
| ALKS | Buy | STOCK | $15,001 - $50,000 |
| NSA | Sell | STOCK | $15,001 - $50,000 |
| MSFT | Buy | STOCK | $15,001 - $50,000 |
The filing shows the largest 6 of 43 disclosed trades: purchases of JPMorgan- and Wells Fargo-linked S&P 500 products, a $50,001-$100,000 MSFT purchase, and sales of TJX, TSLA and PEP. The disclosed high-end total is $1.295 million.
Khanna represents Silicon Valley and often draws scrutiny around tech exposure, so the Microsoft buy and Tesla sale are notable even inside a broader family-account allocation. The structured-note purchases suggest index exposure via bank products rather than a clean single-stock bet.
| JPM | Buy | OTHER | $100,001 - $250,000 |
| WFC | Buy | OTHER | $50,001 - $100,000 |
| MSFT | Buy | STOCK | $50,001 - $100,000 |
| NEW | Sell | STOCK | $15,001 - $50,000 |
| TSLA | Sell | STOCK | $15,001 - $50,000 |
| PEP | Sell | STOCK | $15,001 - $50,000 |
Khosrowshahi filed a Form 4 showing an open-market purchase of 141,000 UBER shares at an average price of $70.9642. The total reported value was $10,005,952.20, increasing reported ownership to 1,367,100 shares.
Open-market CEO purchases of this size are rare and materially stronger than grants or option exercises. The market should read this as a high-conviction insider signal unless later filings show it was part of a pre-arranged program.
Fieldly reported an open-market purchase of 18,000 CELH shares at an average price of $27.4357. The purchase totaled $493,842.60 and lifted reported ownership to 956,063 shares.
A CEO buy near $500,000 is a clean conviction signal, particularly in a consumer-growth name where sentiment can swing hard on scanner data and margin expectations. Watch whether other Celsius insiders follow.
Schwartz filed a Form 4 reporting a purchase of 3,450 OPFI shares at an average price of $7.5914. The total value was $26,190.33, with reported ownership rising to 633,308 shares.
The dollar amount is modest, but open-market CEO buying still outranks routine equity awards. For a consumer-finance name, insider buying can help frame management confidence around credit quality and funding conditions.
Stein's amended Form 4 reports an open-market purchase of 300 RBA shares at $81.14 per share. The disclosed transaction value was $24,342, bringing reported ownership to 2,125 shares.
Director purchases are usually smaller than CEO buys, but this is still a direct cash commitment rather than compensation stock. The amendment status makes the timing worth checking against the original filing.
Patman reported buying 5,219 BRN shares at $1.00 per share, for a total value of $5,219. The filing shows reported ownership of 5,219 shares after the transaction.
The purchase is small, but a CFO's first disclosed stake can matter more than the dollar amount in a thinly followed micro/small-cap name. It is a watch-list signal, not a stand-alone thesis.
| Company / Issuer | Filed | Source |
|---|---|---|
| Sphere 3D Corp. | 2026-09-10 | EDGAR ↗ |
| Sphere 3D Corp. | 2026-09-10 | EDGAR ↗ |
| Sphere 3D Corp. | 2026-09-10 | EDGAR ↗ |
| SOUTHERN MISSOURI BANCORP, INC. | 2026-09-10 | EDGAR ↗ |
| Aquestive Therapeutics, Inc. | 2026-09-10 | EDGAR ↗ |
| RB GLOBAL INC. | 2026-09-10 | EDGAR ↗ |
| RB GLOBAL INC. | 2026-09-10 | EDGAR ↗ |
| Light & Wonder, Inc. | 2026-09-10 | EDGAR ↗ |
| UNIVERSAL SAFETY PRODUCTS, INC. | 2026-09-10 | EDGAR ↗ |
| BARNWELL INDUSTRIES INC | 2026-09-10 | EDGAR ↗ |
The 8-K discloses an underwritten public offering of $500 million of 5.000% senior notes due 2029, $1.0 billion of 5.600% notes due 2033, $750 million of 5.800% notes due 2036, and $500 million of 6.400% notes due 2056. The underwriting agreement was dated September 8, 2026.
The size and long-dated coupons make this more than routine treasury housekeeping for a pipeline operator. The risk is buried under Items 7.01 and 8.01 rather than a headline earnings release, so watch leverage, interest expense and how proceeds are deployed.
Axogen entered a merger agreement to acquire BioCircuit Technologies for a $200.0 million base cash purchase price, subject to customary adjustments. The filing says $1.0 million will be withheld for post-closing adjustments, representations and warranties do not survive closing, and Axogen obtained representation and warranty insurance.
A $200 million cash acquisition is a major strategic swing for a medtech company, and the no-survival language shifts post-close protection onto insurance and closing mechanics. The key watch is whether BioCircuit's NerveTape and ConformaWrap assets can justify the cash outlay without integration or reimbursement friction.
ACV entered a merger agreement with Copart and its merger subsidiary under which Copart will launch a cash tender offer for all ACV shares at $10.50 per share. The offer is expected within 5 business days if practicable, no later than 7 business days, and remains subject to conditions including a majority tender threshold and Hart-Scott-Rodino clearance.
The headline is a takeout, but the tradable risk is in the conditions and tender mechanics. Any spread in ACVA now reflects regulatory timing, shareholder tender participation and whether the auto-auction combination draws antitrust scrutiny.
MercadoLibre and several subsidiaries entered an underwriting agreement for $1,000 million aggregate principal amount of 5.850% notes due 2036. The underwriters include BofA, Citi, Goldman Sachs, J.P. Morgan and Morgan Stanley.
For a premium-growth LatAm platform, incremental long-term debt affects the balance between expansion capital and future interest burden. The filing reads like a standard Item 1.01 financing document, which is exactly where large capital-structure moves can be underweighted by equity investors.
3M closed the sale of €500 million of 3.500% notes due 2028, €500 million of 3.900% notes due 2031, and €500 million of 4.100% notes due 2034. The filing says net proceeds are intended for general corporate purposes, which may include repayment, redemption or refinancing of indebtedness.
This is a large multi-tranche financing by an industrial bellwether, not just exhibit cleanup. The risk sits in future refinancing costs and balance-sheet flexibility as 3M continues to manage legacy liabilities and capital allocation.
| Company / Issuer | Filed | Source |
|---|---|---|
| ARC Group Acquisition I Corp. (ARCL, ARCLR, ARCLU, ARCLW) | 2026-09-10 | EDGAR ↗ |
| COPART INC (CPRT) | 2026-09-10 | EDGAR ↗ |
| PAVmed Inc. (PAVM) | 2026-09-10 | EDGAR ↗ |
| Ingram Micro Holding Corp (INGM) | 2026-09-10 | EDGAR ↗ |
| First Internet Bancorp (INBK, INBKZ) | 2026-09-10 | EDGAR ↗ |
| Autodesk, Inc. (ADSK) | 2026-09-10 | EDGAR ↗ |
| CERENOME, INC. (CNSY) | 2026-09-10 | EDGAR ↗ |
| Dell Technologies Inc. (DELL) | 2026-09-10 | EDGAR ↗ |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | 2026-09-10 | EDGAR ↗ |
| Parker-Hannifin Corp (PH) | 2026-09-10 | EDGAR ↗ |
| AAPL | $326.57 | +0.24% |
| MSFT | $492.44 | +0.46% |
| NVDA | $218.36 | +0.28% |
| AMZN | $251.89 | +0.23% |
| GOOGL | $332.60 | +0.42% |
| META | $644.38 | +0.49% |
| TSLA | $363.56 | +0.04% |
| NFLX | $76.01 | -0.24% |
| JPM | $353.56 | +-0.00% |
| AMD | $503.60 | +0.32% |
| SWKS | +9.8% | $84.03 |
| QRVO | +6.8% | $112.36 |
| VEON | +6.4% | $69.16 |
| RDDT | +6.1% | $155.34 |
| ASO | +6.0% | $54.22 |
| VIST | +5.9% | $78.95 |
| INTR | +5.5% | $5.78 |
| PAGS | +5.4% | $10.13 |
| ELV | +5.4% | $416.54 |
| CRUS | +5.2% | $116.48 |
| BSP | +5.1% | $39.67 |
| MNDY | +5.0% | $85.17 |
| CHTR | +5.0% | $140.56 |
| STNE | +4.9% | $10.30 |
| XP | +4.9% | $19.97 |
| BAH | +4.8% | $75.68 |
| RDNT | +4.8% | $74.28 |
| IOND | +4.8% | $79.88 |
| TRMD | +4.7% | $34.60 |
| FOUR | +4.6% | $43.03 |
| RML | -26.5% | $8.53 |
| NAVN | -21.8% | $20.26 |
| COO | -14.7% | $54.17 |
| AEO | -14.0% | $14.53 |
| AXGN | -11.5% | $41.85 |
| TGB | -10.2% | $8.02 |
| ALM | -9.6% | $16.57 |
| RELY | -8.9% | $21.93 |
| FRVO | -8.8% | $15.73 |
| LEU | -8.6% | $165.87 |
| ERO | -8.6% | $34.98 |
| PURR | -8.5% | $11.01 |
| XE | -8.3% | $15.84 |
| RCUS | -8.2% | $26.15 |
| LECO | -7.5% | $251.06 |
| HBM | -7.5% | $26.65 |
| OCUL | -7.4% | $10.62 |
| SCCO | -7.2% | $194.14 |
| CENX | -7.0% | $44.36 |
| SRPT | -6.8% | $20.52 |